Predict your next investment

SRI International company logo
Non-Profit Foundation
HEALTHCARE | Drug Development
sri.com

See what CB Insights has to offer

Investments

15

Portfolio Exits

6

Partners & Customers

10

About SRI International

SRI International is a nonprofit, independent research and innovation center serving government and industry. The company provides basic and applied research, laboratory and advisory services, technology development and licenses, deployable systems, products, and venture opportunities.

SRI International Headquarter Location

333 Ravenswood Avenue

Menlo Park, California, 94025,

United States

650-859-2000

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing SRI International

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Find SRI International in 1 Expert Collection, including Biopharma Tech.

B

Biopharma Tech

15,535 items

Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.

SRI International Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

SRI International Rank

Latest SRI International News

NIST Awards SRI International $299,128 for Development of a Quantum Technology Manufacturing Roadmap

May 21, 2022

The funding will support a roadmap that identifies pre-competitive development and supply chain gaps to help maintain U.S. dominance in quantum-related fields to benefit multiple quantum technology application areas. The award was part of NIST's Advanced Manufacturing Technology Roadmap (MFGTech) Program which provided a total of seven awards in a variety of fields. Additional information about [...] The post NIST Awards SRI International $299,128 for Development of a Quantum Technology Manufacturing Roadmap appeared first on Quantum Computing Report.

SRI International Investments

15 Investments

SRI International has made 15 investments. Their latest investment was in AccuKnox as part of their Seed VC on April 4, 2021.

CBI Logo

SRI International Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

4/27/2021

Seed VC

AccuKnox

$4.6M

Yes

11

6/17/2020

Series A

Authenticiti

Yes

1

8/16/2019

Seed VC

OTO Systems

$5.39M

Yes

2

1/9/2018

Seed VC

Subscribe to see more

$99M

Subscribe to see more

10

2/27/2017

Seed VC

Subscribe to see more

$99M

Subscribe to see more

10

Date

4/27/2021

6/17/2020

8/16/2019

1/9/2018

2/27/2017

Round

Seed VC

Series A

Seed VC

Seed VC

Seed VC

Company

AccuKnox

Authenticiti

OTO Systems

Subscribe to see more

Subscribe to see more

Amount

$4.6M

$5.39M

$99M

$99M

New?

Yes

Yes

Yes

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

11

1

2

10

10

SRI International Portfolio Exits

6 Portfolio Exits

SRI International has 6 portfolio exits. Their latest portfolio exit was OTO Systems on August 24, 2021.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

8/24/2021

Acquired

6

8/21/2019

Acquired

Subscribe to see more

Subscribe to see more

10

5/29/2015

Acquired

Subscribe to see more

Subscribe to see more

10

5/30/2014

Acquired

Subscribe to see more

Subscribe to see more

10

11/9/2001

Acquired

Subscribe to see more

Subscribe to see more

0

Date

8/24/2021

8/21/2019

5/29/2015

5/30/2014

11/9/2001

Exit

Acquired

Acquired

Acquired

Acquired

Acquired

Companies

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Valuation

Acquirer

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Sources

6

10

10

10

0

SRI International Acquisitions

1 Acquisition

SRI International acquired 1 company. Their latest acquisition was PacketHop on January 08, 2007.

Date

Investment Stage

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Total Funding

Note

Sources

1/8/2007

Series C

$99M

$25M

Acquired

Date

1/8/2007

Investment Stage

Series C

Companies

Valuation

$99M

Total Funding

$25M

Note

Acquired

Sources

SRI International Partners & Customers

10 Partners and customers

SRI International has 10 strategic partners and customers. SRI International recently partnered with Janssen Pharmaceuticals on January 1, 2022.

Date

Type

Business Partner

Country

News Snippet

Sources

1/5/2022

Licensee

United States

SRI International announces collaboration agreement with Janssen - SRI International

MENLO PARK , Calif. , Jan. 5 , 2022 / PRNewswire / -- SRI International today announced the company has entered into a collaboration agreement with Janssen Pharmaceutica NV , one of the Janssen .

1

1/5/2022

Licensee

United States

SRI International announces collaboration agreement with Janssen - SRI International

MENLO PARK , Calif. , Jan. 5 , 2022 / PRNewswire / -- SRI International today announced the company has entered into a collaboration agreement with Janssen Pharmaceutica NV , one of the Janssen .

1

12/9/2021

Client

United States

SRI Bioscience awarded $14.7 million contract to continue development of high-concentration Naloxone formulation - SRI International

MENLO PARK , CA -LRB- December 8 , 2021 -RRB- -- SRI has been awarded a $ 14.7 million contract sponsored by the Defense Threat Reduction Agency through the Medical , Chemical , Biological , Radiological , and Nuclear Defense Consortium -LRB- MCDC -RRB- to continue development of a high-concentration naloxone product for intravenous , intramuscular and subcutaneous injection , or intravenous infusion .

1

12/8/2021

Client

United States

Subscribe to see more

Subscribe to see more

10

7/7/2021

Client

France

Subscribe to see more

Subscribe to see more

10

Date

1/5/2022

1/5/2022

12/9/2021

12/8/2021

7/7/2021

Type

Licensee

Licensee

Client

Client

Client

Business Partner

Country

United States

United States

United States

United States

France

News Snippet

SRI International announces collaboration agreement with Janssen - SRI International

MENLO PARK , Calif. , Jan. 5 , 2022 / PRNewswire / -- SRI International today announced the company has entered into a collaboration agreement with Janssen Pharmaceutica NV , one of the Janssen .

SRI International announces collaboration agreement with Janssen - SRI International

MENLO PARK , Calif. , Jan. 5 , 2022 / PRNewswire / -- SRI International today announced the company has entered into a collaboration agreement with Janssen Pharmaceutica NV , one of the Janssen .

SRI Bioscience awarded $14.7 million contract to continue development of high-concentration Naloxone formulation - SRI International

MENLO PARK , CA -LRB- December 8 , 2021 -RRB- -- SRI has been awarded a $ 14.7 million contract sponsored by the Defense Threat Reduction Agency through the Medical , Chemical , Biological , Radiological , and Nuclear Defense Consortium -LRB- MCDC -RRB- to continue development of a high-concentration naloxone product for intravenous , intramuscular and subcutaneous injection , or intravenous infusion .

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Sources

1

1

1

10

10

SRI International Team

16 Team Members

SRI International has 16 team members, including current President, Steve Ciesinski.

Name

Work History

Title

Status

Steve Ciesinski

President

Current

William Mark

President

Current

Stephanie DeFino

Chief Financial Officer

Current

Jim Doyle MBA

Chief Financial Officer

Current

Mike Page

Chief Information Officer, Senior Vice President

Current

Name

Steve Ciesinski

William Mark

Stephanie DeFino

Jim Doyle MBA

Mike Page

Work History

Title

President

President

Chief Financial Officer

Chief Financial Officer

Chief Information Officer, Senior Vice President

Status

Current

Current

Current

Current

Current

You May Also Like

Sarcos Robotics Logo
Sarcos Robotics

Sarcos Corp, aka Sarcos Robotics, is a global provider in the development and production of robotic systems for use in unstructured environments. Sarcos is producing human-controlled robots to improve health, safety, and quality of life by keeping humans out of harm's way.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.